Mice lacking inducible nitric oxide synthase develop exacerbated hepatic inflammatory responses induced by Plasmodium berghei NK65 infection

Microbes and Infection

Volumn 15, Issue 13, 2013, Pages 903-910

  Oliveira Lima, Onésia Cristina ^a   Bernardes, Danielle ^a   Xavier Pinto, Mauro Cunha ^a   Esteves Arantes, Rosa Maria ^a   Carvalho Tavares, Juliana ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Experimental malaria; Inducible nitric oxide synthase; Inflammation; Leukocyte recruitment; Liver

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; FEMALE; HEPATITIS; HISTOPATHOLOGY; INFLAMMATION; INTRAVITAL MICROSCOPY; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LIVER; LIVER INJURY; MICROSCOPY; MICROVASCULATURE; MORTALITY; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TISSUE INJURY; WILD TYPE;

ANIMALIA; MURINAE; MUS; PLASMODIUM BERGHEI;

EXPERIMENTAL MALARIA; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATION; LEUKOCYTE RECRUITMENT; LIVER;

ANIMALS; CYTOKINES; HEPATITIS; LIVER; MALARIA; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PLASMODIUM BERGHEI; SURVIVAL ANALYSIS;

EID: 84888017425     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.08.001     Document Type: Article

References (48)

1. WHO World Malaria Report 2011 2011.
2. Adachi K., Tsutsui H., Kashiwamura S., Seki E., Nakano H., Takeuchi O., Takeda K., Okumura K., Van Kaer L., Okamura H., Akira S., Nakanishi K. Plasmodium berghei infection in mice induces liver injury by an IL-12-and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 2001, 167:5928-5934.
3. Lacerda-Queiroz N., Lima O.C., Carneiro C.M., Vilela M.C., Teixeira A.L., Carvalho A.T., Araujo M.S., Martins-Filho O.A., Braga E.M., Carvalho-Tavares J. Plasmodium berghei NK65 induces cerebral leukocyte recruitment invivo: an intravital microscopic study. Acta Trop. 2011, 31-39.
4. Yoshimoto T., Takahama Y., Wang C.R., Yoneto T., Waki S., Nariuchi H. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J. Immunol. 1998, 160:5500-5505.
5. Bogdan C., Rollinghoff M., Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 2000, 173:17-26.
6. Nussler A.K., Geller D.A., Sweetland M.A., Di Silvio M., Billiar T.R., Madariaga J.B., Simmons R.L., Lancaster J.R. Induction of nitric oxide synthesis and its reactions in cultured human and rat hepatocytes stimulated with cytokines plus LPS. Biochem. Biophys. Res. Commun. 1993, 194:826-835.
7. Vos T.A., Van Goor H., Tuyt L., De Jager-Krikken A., Leuvenink R., Kuipers F., Jansen P.L., Moshage H. Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status. Hepatology 1999, 29:421-426.
8. Ghigo D., Todde R., Ginsburg H., Costamagna C., Gautret P., Bussolino F., Ulliers D., Giribaldi G., Deharo E., Gabrielli G., Pescarmona G., Bosia A. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor. J. Exp. Med. 1995, 182:677-688.
9. Tachado S.D., Gerold P., McConville M.J., Baldwin T., Quilici D., Schwarz R.T., Schofield L. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol. 1996, 156:1897-1907.
10. Jaramillo M., Gowda D.C., Radzioch D., Olivier M. Hemozoin increases IFN-gamma-inducible macrophage nitric oxide generation through extracellular signal-regulated kinase- and NF-kappa B-dependent pathways. J. Immunol. 2003, 171:4243-4253.
11. Nahrevanian H., Dascombe M.J. Expression of inducible nitric oxide synthase (iNOS) mRNA in target organs of lethal and non-lethal strains of murine malaria. Parasite Immunol. 2002, 24:471-478.
12. Nahrevanian H., Dascombe M.J. Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria. Parasite Immunol. 2001, 23:491-501.
13. Chiwakata C.B., Hemmer C.J., Dietrich M. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Infect. Immun. 2000, 68:394-399.
14. Luster A.D., Alon R., von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 2005, 6:1182-1190.
15. Cabrales P., Zanini G.M., Meays D., Frangos J.A., Carvalho L.J. Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J. Infect. Dis. 2011, 203:1454-1463.
16. Zanini G.M., Cabrales P., Barkho W., Frangos J.A., Carvalho L.J. Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. J. Neuroinflammation 2011, 8:66.
17. Hickey M.J., Sharkey K.A., Sihota E.G., Reinhardt P.H., Macmicking J.D., Nathan C., Kubes P. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 1997, 11:955-964.
18. Hickey M.J., Granger D.N., Kubes P. Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol. Scand. 2001, 173:119-126.
19. Schofield L., Grau G.E. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 2005, 5:722-735.
20. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lackinginducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:10688-10692.
21. Carvalho-Tavares J., Fox-Robichaud A., Kubes P. Assessment of the mechanism of juxtacrine activation and adhesion of leukocytes in liver microcirculation. Am. J. Physiol. 1999, 276:G828-G834.
22. Lamb T.J., Brown D.E., Potocnik A.J., Langhorne J. Insights into the immunopathogenesis of malaria using mouse models. Expert Rev. Mol. Med. 2006, 8:1-22.
23. Favre N., Ryffel B., Rudin W. Parasite killing in murine malaria does not require nitric oxide production. Parasitology 1999, 118:139-143.
24. Yoneto T., Yoshimoto T., Wang C.R., Takahama Y., Tsuji M., Waki S., Nariuchi H. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect. Immun. 1999, 67:2349-2356.
25. Gramaglia I., Sobolewski P., Meays D., Contreras R., Nolan J.P., Frangos J.A., Intaglietta M., van der Heyde H.C. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med. 2006, 12:1417-1422.
26. Gillman B.M., Batchelder J., Flaherty P., Weidanz W.P. Suppression of Plasmodium chabaudi parasitemia is independent of the action of reactive oxygen intermediates and/or nitric oxide. Infect. Immun. 2004, 72:6359-6366.
27. Garnica M.R., Silva J.S., de Andrade Junior H.F. Stromal cell-derived factor-1 production by spleen cells is affected by nitric oxide in protective immunity against blood-stage Plasmodium chabaudi CR in C57BL/6j mice. Immunol. Lett. 2003, 89:133-142.
28. Liu L., Kubes P. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb. Haemost. 2003, 89:213-220.
29. Benjamim C.F., Silva J.S., Fortes Z.B., Oliveira M.A., Ferreira S.H., Cunha F.Q. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect. Immun. 2002, 70:3602-3610.
30. McCafferty D.M., Mudgett J.S., Swain M.G., Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997, 112:1022-1027.
31. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2001, 2:907-916.
32. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 1995, 96:60-68.
33. Banick P.D., Chen Q., Xu Y.A., Thom S.R. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J. Cell Physiol. 1997, 172:12-24.
34. Giannini E.G., Testa R., Savarino V. Liver enzyme alteration: a guide for clinicians. Can. Med. Assoc. J. 2005, 172:367-379.
35. Tangpukdee N., Thanachartwet V., Krudsood S., Luplertlop N., Pornpininworakij K., Chalermrut K., Phokham S., Kano S., Looareesuwan S., Wilairatana P. Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment. Korean J. Parasitol. 2006, 44:295-302.
36. Niikura M., Kamiya S., Kita K., Kobayashi F. Coinfection with non-lethal murine malaria parasites suppresses pathogenesis caused by Plasmodium berghei NK65. J. Immunol. 2008, 180:6877-6884.
37. Frevert U., Engelmann S., Zougbede S., Stange J., Ng B., Matuschewski K., Liebes L., Yee H. Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol. 2005, 3:e192.
38. Iwalokun B.A., Bamiro S.B., Ogunledun A. Levels and interactions of plasma xanthine oxidase, catalase and liver function parameters in Nigerian children with Plasmodium falciparum infection. Acta Pathol. Microbiol. Immunol. Scand. 2006, 114:842-850.
39. Waki S., Uehara S., Kanbe K., Ono K., Suzuki M., Nariuchi H. The role of T cells in pathogenesis and protective immunity to murine malaria. Immunology 1992, 75:646-651.
40. Findlay E.G., Greig R., Stumhofer J.S., Hafalla J.C., de Souza J.B., Saris C.J., Hunter C.A., Riley E.M., Couper K.N. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J. Immunol. 2010, 185:2482-2492.
41. Seixas E., Oliveira P., Moura Nunes J.F., Coutinho A. An experimental model for fatal malaria due to TNF-alpha-dependent hepatic damage. Parasitology 2008, 135:683-690.
42. Wilairatana P., Looareesuwan S., Charoenlarp P. Liver profile changes and complications in jaundiced patients with falciparum malaria. Trop. Med. Parasitol. 1994, 45:298-302.
43. Rudin W., Eugster H.P., Bordmann G., Bonato J., Muller M., Yamage M., Ryffel B. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am. J. Pathol. 1997, 150:257-266.
44. Serghides L., Kim H., Lu Z., Kain D.C., Miller C., Francis R.C., Liles W.C., Zapol W.M., Kain K.C. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One 2011, 6:e27714.
45. Brouckaert P., Spriggs D.R., Demetri G., Kufe D.W., Fiers W. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J. Exp. Med. 1989, 169:2257-2262.
46. Grau G.E., Frei K., Piguet P.F., Fontana A., Heremans H., Billiau A., Vassalli P., Lambert P.H. Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J. Exp. Med. 1990, 172:1505-1508.
47. Kern P., Hemmer C.J., Van Damme J., Gruss H.J., Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 1989, 87:139-143.
48. Niikura M., Inoue S., Kobayashi F. Role of interleukin-10 in malaria: focusing on coinfection with lethal and nonlethal murine malaria parasites. J. Biomed. Biotechnol. 2011, 2011:383962.